| 000 -LEADER |
|---|
| fixed length control field |
04125nam a22004575i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150234.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110728s2011 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781441996312 |
|
978-1-4419-9631-2 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM1-950 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Boston, MA : |
| -- |
Springer US, |
| -- |
2011. |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nickerson, Beverly. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Sample Preparation of Pharmaceutical Dosage Forms |
| Medium |
[electronic resource] : |
| Remainder of title |
Challenges and Strategies for Sample Preparation and Extraction / |
| Statement of responsibility, etc |
edited by Beverly Nickerson. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XIV, 397p. 88 illus., 31 illus. in color. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Properties that Impact Sample Preparation and Extraction of Pharmaceutical Dosage Forms -- Sampling Considerations -- Agitation and Particle Size Reduction Techniques -- Liquid-Liquid and Solid-Phase Extraction Techniques -- Extraction Techniques Leveraging Elevated Temperature and Pressure -- Addressing Drug-Excipient Interactions -- Sample Preparation for Solid Oral Dosage Forms -- Sample Preparation for Select Non Solid Dosage Forms -- Post-Extraction Considerations -- Sample Preparation Method Validation -- Application of Quality by Design (QbD) Principles for Sample Preparation -- Automation and Sample Preparation -- A Systematic Approach for Investigating Aberrant Potency Values -- Green Chemistry Considerations for Sample Preparation -- No Sample Preparation. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Designed as a resource guide for analytical scientists working in the pharmaceutical industry, this comprehensive guide is focused entirely on sample preparation and extraction of pharmaceutical dosage forms. This book is divided into four parts: • Part One covers dosage form and diluent properties that impact sample preparation of pharmaceutical dosage forms and the importance of sampling considerations in generating data representative of the drug product batch. • Part Two reviews specific sample preparation techniques typically used with pharmaceutical dosage forms. • Part Three discusses sample preparation method development for different types of dosage forms including addressing drug excipient interactions and post extraction considerations, as well as method validation and applying Quality by Design (QbD) principles to sample preparation methods. • Part Four examines additional topics in sample preparation including automation, investigating aberrant potency results, green chemistry considerations for sample preparation and the ideal case where no sample preparation is required for sample analysis. Analytical scientists in the pharmaceutical industry as well as in analytical testing laboratories will find this book a valuable resource in developing and troubleshooting sample preparation methods for drug products at all stages in the lifecycle of a drug product. Beverly Nickerson, Ph.D., is Associate Research Fellow in Analytical Development in Pfizer Global Research and Development, Pfizer Inc. Dr. Nickerson is well published in peer-reviewed journals, is author of several book chapters and has presented at various scientific meetings. She has extensive experience in early stage and late stage drug development. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Toxicology. |
|
|---|
| Topical term or geographic name as entry element |
Pharmaceutical technology. |
|
|---|
| Topical term or geographic name as entry element |
Pharmacy. |
|
|---|
| Topical term or geographic name as entry element |
Biochemistry. |
|
|---|
| Topical term or geographic name as entry element |
Biomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Pharmacology/Toxicology. |
|
|---|
| Topical term or geographic name as entry element |
Pharmaceutical Sciences/Technology. |
|
|---|
| Topical term or geographic name as entry element |
Biochemistry, general. |
|
|---|
| Topical term or geographic name as entry element |
Pharmacy. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781441996305 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4419-9631-2 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
